ACTH Deficiency, Higher Doses of Hydrocortisone Replacement, and Radiotherapy Are Independent Predictors of Mortality in Patients with Acromegaly
The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Context A number of retrospective studies report that patients with acromegaly have increased morbidity and premature mortality, with standardized mortality ratios (SMR) of 1.3-3. Many patients with acromegaly develop hypopituitarism as a result of the pituitary adenoma itself or therapies such as surgery and radiotherapy. Pituitary radiotherapy and hypopituitarism have also been associated with an increased SMR. Methods Using the West MIDLANDS: Acromegaly database (n = 501; 275 female), we assessed the influence of prior radiotherapy and hypopituitarism (and replacement therapy) on mortality in patients with acromegaly. Median duration of follow-up was 14.0 yr (interquartile range, 7.9-21 yr). Results All-cause mortality was elevated [SMR, 1.7 (1.4, 2.0); P Conclusions Radiotherapy and ACTH deficiency are significantly associated with increased mortality in patients with acromegaly. In ACTH-deficient patients, a daily dose of more than 25 mg hydrocortisone is associated with increased mortality compared to lower doses. These results have important implications for the treatment of patients with acromegaly and also raise issues as to the optimum hydrocortisone treatment regimens for ACTH-deficient patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Higher GC replacement doses in patients with ACTH deficiency are associated with increased overall and cardiovascular mortality; the greatest risk is in patients receiving daily HC doses higher or equal to 30 mg (8).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [8]
In the citing paper
“Higher GC replacement doses in patients with ACTH deficiency are associated with increased overall and cardiovascular mortality; the greatest risk is in patients receiving daily HC doses higher or equal to 30 mg (8).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [8]
In the citing paper
“It has become increasingly evident that, even in patients with treated AI, there continues to be significant morbidity and reduced life expectancy.5–7”
From Adrenal crisis: prevention and management in adult patients (2019) · cites this paper as [6]
Citations
Cites
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,592
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
Colao, A., Ferone, D., Marzullo, P., & Lombardi, G. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0022 · Cited by 1,309
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
Self-citation11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969
Self-citationMortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study1
Orme, S. M., McNally, R. J. Q., Cartwright, R. A., & Belchetz, P. E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5007 · Cited by 805
Statistical methods in cancer research
Gardner, B. (2001) · Journal of Surgical Oncology · doi:10.1002/jso.1170 · Cited by 777
Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease
Wei, L., MacDonald, T. M., & Walker, B. R. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00007 · Cited by 730
Factors Influencing Mortality in Acromegaly
Holdaway, I. M., Rajasoorya, R. C., & Gamble, G. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031199 · Cited by 651
Research works printed but not linked: 1
- Fajardo, 1999, Is the pathology of radiation injury different in small vs large blood vessels?, Cardiovasc Radiat Med, 1, 108
Cited by
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
A Consensus Statement on acromegaly therapeutic outcomes
Melmed, S., Bronstein, M. D., Chanson, P., Klibanski, A., Casanueva, F. F., Wass, J. A. H., Strasburger, C. J., Luger, A., Clemmons, D. R., & Giustina, A. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0058-5 · Cited by 561
Mortality in Patients with Pituitary Disease
Sherlock, M., Ayuk, J., Tomlinson, J. W., Toogood, A. A., Aragon-Alonso, A., Sheppard, M. C., Bates, A. S., & Stewart, P. M. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0033 · Cited by 392
Self-citationA Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
Giustina, A., Barkan, A., Beckers, A., Biermasz, N., Biller, B. M. K., Boguszewski, C., Bolanowski, M., Bonert, V., Bronstein, M. D., Casanueva, F. F., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz096 · Cited by 371
Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update
Gadelha, M. R., Kasuki, L., Lim, D. S. T., & Fleseriu, M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00115 · Cited by 363
A consensus on the diagnosis and treatment of acromegaly complications
Melmed, S., Casanueva, F. F., Klibanski, A., Bronstein, M. D., Chanson, P., Lamberts, S. W., Strasburger, C. J., Wass, J. A. H., & Giustina, A. (2013) · Pituitary · doi:10.1007/s11102-012-0420-x · Cited by 325
Acromegaly: pathogenesis, diagnosis, and management
Fleseriu, M., Langlois, F., Lim, D. S. T., Varlamov, E. V., & Melmed, S. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00244-3 · Cited by 279
Predictors of morbidity and mortality in acromegaly: an Italian survey
Arosio, M., Reimondo, G., Malchiodi, E., Berchialla, P., Borraccino, A., De Marinis, L., Pivonello, R., Grottoli, S., Losa, M., Cannavò, S., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0084 · Cited by 219
Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?
Pofi, R., Caratti, G., Ray, D. W., & Tomlinson, J. W. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad016 · Cited by 209
Clayton, R. N., Jones, P. W., Reulen, R. C., Stewart, P. M., Hassan-Smith, Z. K., Ntali, G., Karavitaki, N., Dekkers, O. M., Pereira, A. M., Bolland, M., et al. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30005-5 · Cited by 208
Self-citationMercado, M., Gonzalez, B., Vargas, G., Ramirez, C., de los Monteros, A. L. E., Sosa, E., Jervis, P., Roldan, P., Mendoza, V., López-Félix, B., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2670 · Cited by 199
Olsson, D. S., Andersson, E., Bryngelsson, I.-L., Nilsson, A. G., & Johannsson, G. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3525 · Cited by 194
The Diagnosis and Management of Central Hypoadrenalism
Grossman, A. B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0982 · Cited by 187
Burman, P., Mattsson, A. F., Johannsson, G., Höybye, C., Holmer, H., Dahlqvist, P., Berinder, K., Engström, B. E., Ekman, B., Erfurth, E. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4059 · Cited by 184
“In support of a clinical relevance of lowered hydrocortisone replacement doses in hypopituitarism is the association between daily doses above 20 mg and a worsened cardiovascular risk profile (27), and a relation between hydrocortisone doses and cardiovascular mortality in acromegaly (28).”
Mortality and morbidity in Cushing's syndrome in New Zealand
Bolland, M. J., Holdaway, I. M., Berkeley, J. E., Lim, S., Dransfield, W. J., Conaglen, J. V., Croxson, M. S., Gamble, G. D., Hunt, P. J., & Toomath, R. J. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04124.x · Cited by 182
Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis
Bolfi, F., Neves, A. F., Boguszewski, C. L., & Nunes-Nogueira, V. S. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0255 · Cited by 182
Mortality in acromegaly: a 20-year follow-up study
Ritvonen, E., Löyttyniemi, E., Jaatinen, P., Ebeling, T., Moilanen, L., Nuutila, P., Kauppinen-Mäkelin, R., & Schalin-Jäntti, C. (2016) · Endocrine-Related Cancer · doi:10.1530/erc-16-0106 · Cited by 173
“1998, Sherlock et al .”
Mortality and morbidity in adult craniopharyngioma
Erfurth, E. M., Holmer, H., & Fjalldal, S. B. (2012) · Pituitary · doi:10.1007/s11102-012-0428-2 · Cited by 163
Clinical, quality of life, and economic value of acromegaly disease control
Ben-Shlomo, A., Sheppard, M. C., Stephens, J. M., Pulgar, S., & Melmed, S. (2011) · Pituitary · doi:10.1007/s11102-011-0310-7 · Cited by 159
Self-citationClinical Manifestations and Diagnosis of Acromegaly
Lugo, G., Pena, L., & Cordido, F. (2012) · International Journal of Endocrinology · doi:10.1155/2012/540398 · Cited by 155
Growth Hormone’s Links to Cancer
Boguszewski, C. L., & Boguszewski, M. C. D. S. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00166 · Cited by 146
Overall and Disease-Specific Mortality in Patients With Cushing Disease: A Swedish Nationwide Study
Ragnarsson, O., Olsson, D. S., Papakokkinou, E., Chantzichristos, D., Dahlqvist, P., Segerstedt, E., Olsson, T., Petersson, M., Berinder, K., Bensing, S., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02524 · Cited by 134
Adrenal crisis: prevention and management in adult patients
Dineen, R., Thompson, C. J., & Sherlock, M. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819848218 · Cited by 123
Self-citationAdrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy
Johannsson, G., Falorni, A., Skrtic, S., Lennernäs, H., Quinkler, M., Monson, J. P., & Stewart, P. M. (2015) · Clinical Endocrinology · doi:10.1111/cen.12603 · Cited by 122
Self-citationJung, C., Greco, S., Nguyen, H. H., Ho, J. T., Lewis, J. G., Torpy, D. J., & Inder, W. J. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-91 · Cited by 114
“Despite evidence of increased mortality with hydrocortisone doses above 25–30 mg per day [9,11], this dose is still widely used in clinical practice.”
BackgroundThe changing face of acromegaly—advances in diagnosis and treatment
Ribeiro‐Oliveira, A., & Barkan, A. L. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.101 · Cited by 113
Olsson, D. S., Nilsson, A. G., Bryngelsson, I.-L., Trimpou, P., Johannsson, G., & Andersson, E. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1475 · Cited by 110
Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia
Merke, D. P., Mallappa, A., Arlt, W., Brac de la Perriere, A., Lindén Hirschberg, A., Juul, A., Newell-Price, J., Perry, C. G., Prete, A., Rees, D. A., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab051 · Cited by 109
“Age, y, median (range) 35 (19-61) 40 (19-68) 35 (20-67)”
The nodularity of nodular goitre.
Taylor, S. (1973) · PubMed · Cited by 109
Esposito, D., Ragnarsson, O., Granfeldt, D., Marlow, T., Johannsson, G., & Olsson, D. S. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0015 · Cited by 105
Cossu, G., Jouanneau, E., Cavallo, L. M., Elbabaa, S. K., Giammattei, L., Starnoni, D., Barges-Coll, J., Cappabianca, P., Beneš, V., Başkaya, M. K., et al. (2020) · Acta Neurochirurgica · doi:10.1007/s00701-020-04265-1 · Cited by 95
Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma
Zueger, T., Kirchner, P., Herren, C., Fischli, S., Zwahlen, M., Christ, E., & Stettler, C. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2432 · Cited by 90
Adrenal Cortical Insufficiency
Quinkler, M. O., Beuschlein, F., Hahner, S., Meyer, G., Schöfl, C., & Stalla, G. K. (2013) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2013.0882 · Cited by 83
Wang, S., Wang, L., Yao, Y., Feng, F., Yang, H., Liang, Z., Deng, K., You, H., Sun, J. H., Xing, B., et al. (2017) · Clinical Endocrinology · doi:10.1111/cen.13354 · Cited by 75
Determinants of morbidities and mortality in acromegaly
Kasuki, L., Rocha, P., Lamback, E. B., & Gadelha, M. R. (2019) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000193 · Cited by 74
Hammarstrand, C., Ragnarsson, O., Hallén, T., Andersson, E., Skoglund, T., Nilsson, A. G., Johannsson, G., & Olsson, D. S. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0340 · Cited by 70
Giustina, A., Uygur, M. M., Frara, S., Barkan, A., Biermasz, N. R., Chanson, P., Freda, P., Gadelha, M., Kaiser, U. B., Lamberts, S., et al. (2023) · Pituitary · doi:10.1007/s11102-023-01345-0 · Cited by 66
Burt, M. G., Willenberg, V., Petersons, C. J., Smith, M., Ahern, M. J., & Stranks, S. N. (2012) · Rheumatology · doi:10.1093/rheumatology/kes003 · Cited by 64
Ceccato, F., Lombardi, G., Manara, R., Emanuelli, E., Denaro, L., Milanese, L., Gardiman, M. P., Bertorelle, R., Scanarini, M., D’Avella, D., et al. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1702-0 · Cited by 62
A proposed clinical classification for pituitary neoplasms to guide therapy and prognosis
Ho, K. K. Y., Fleseriu, M., Wass, J. A. H., Katznelson, L. J., Raverot, G., Little, A. S., Castano, J. P., Reincke, M., Lopes, M. B. S., Kaiser, U. B., et al. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00382-0 · Cited by 61
Stewart, P. M., & Krone, N. P. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00015-8 · Cited by 61
Self-citationGow, R., Koren, G., Rieder, M., & Van Uum, S. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04001.x · Cited by 60
Quinkler, M., Ekman, B., Marelli, C., Uddin, S., Zelissen, P., Murray, R. D., & _, _. (2017) · Endocrine Connections · doi:10.1530/ec-16-0081 · Cited by 59
Updates in outcomes of stereotactic radiation therapy in acromegaly
Gheorghiu, M. L. (2017) · Pituitary · doi:10.1007/s11102-016-0783-5 · Cited by 56
Petersons, C. J., Mangelsdorf, B. L., Thompson, C. H., & Burt, M. G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4305 · Cited by 54
Bogazzi, F., Colao, A. A. L., Rossi, G., Lombardi, M., Urbani, C., Sardella, C., Iannelli, A., Scattina, I., Manetti, L., Sarto, S. D., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0166 · Cited by 52
Ragnarsson, O., & Johannsson, G. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0534 · Cited by 51
O'Reilly, M. W., Reulen, R. C., Gupta, S., Thompson, C. A., Dineen, R., Goulden, E. L., Bugg, G., Pearce, H., Toogood, A. A., Gittoes, N. J., et al. (2016) · Clinical Endocrinology · doi:10.1111/cen.13141 · Cited by 50
Self-citationCentral adrenal insufficiency: open issues regarding diagnosis and glucocorticoid treatment
Ceccato, F., & Scaroni, C. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2018-0824 · Cited by 49
Smith, D. J. F., Prabhudev, H., Choudhury, S., & Meeran, K. M. (2017) · Endocrine Connections · doi:10.1530/ec-17-0257 · Cited by 49
Olsson, D. S., Bryngelsson, I., & Ragnarsson, Ó. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0173 · Cited by 49
Endocrine Disorder in Patients With Craniopharyngioma
Zhou, Z., Zhang, S., & Hu, F. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.737743 · Cited by 48
Alboqami, M. N., Albaiahy, A., Bukhari, B. H., Alkhaibary, A., Alharbi, A., Khairy, S., Alassiri, A. H., AlSufiani, F., Alkhani, A. M., & Aloraidi, A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32112 · Cited by 48
Management of hypothalamic disease in patients with craniopharyngioma
Thompson, C. J., Costello, R. W., & Crowley, R. K. (2019) · Clinical Endocrinology · doi:10.1111/cen.13929 · Cited by 48
Ragnarsson, O., Mattsson, A. F., Monson, J. P., Filipsson Nyström, H., Åkerblad, A.-C., Kołtowska-Häggström, M., & Johannsson, G. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0397 · Cited by 46
Johannsson, G., & Ragnarsson, Ó. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13382 · Cited by 46
Sattler, M. G. A., van Beek, A. P., Wolffenbuttel, B. H. R., van den Berg, G., Sluiter, W. J., Langendijk, J. A., & van den Bergh, A. C. M. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.04.024 · Cited by 46
Colao, A., Vandeva, S., Pivonello, R., Grasso, L. F. S., Nachev, E., Auriemma, R. S., Kalinov, K., & Zacharieva, S. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-1022 · Cited by 45
Brzana, J. A., Yedinak, C. G., Delashaw, J. B., Gultelkin, H. S., Cook, D. M., & Fleseriu, M. (2011) · Pituitary · doi:10.1007/s11102-011-0369-1 · Cited by 45
The Role of Radiotherapy in Acromegaly
Hannon, M. J., Barkan, A. L., & Drake, W. M. (2015) · Neuroendocrinology · doi:10.1159/000435776 · Cited by 44
Sherlock, M., Reulen, R. C., Alonso, A. A., Ayuk, J., Clayton, R. N., Sheppard, M. C., Hawkins, M. M., Bates, A. S., & Stewart, P. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2450 · Cited by 43
Self-citationTreatment Factors That Influence Mortality in Acromegaly
McCabe, J. J., Ayuk, J., & Sherlock, M. (2015) · Neuroendocrinology · doi:10.1159/000375163 · Cited by 43
Self-citationGroup 2: Adrenal insufficiency: screening methods and confirmation of diagnosis
Chanson, P., Guignat, L., Goichot, B., Chabre, O., Samara‐Boustani, D., Reynaud, R., Simon, D., Tabarin, A., Gruson, D., Reznik, Y., et al. (2017) · Annales d Endocrinologie · doi:10.1016/j.ando.2017.10.005 · Cited by 43
Varadhan, L., Reulen, R. C., Brown, M., & Clayton, R. N. (2016) · Pituitary · doi:10.1007/s11102-015-0700-3 · Cited by 43
Self-citationWang, W., Wang, S., Jiang, Y., Yan, F., Su, T., Zhou, W., Jiang, L., Zhang, Y., & Ning, G. (2015) · Clinical Endocrinology · doi:10.1111/cen.12788 · Cited by 42
Iatrogenic adrenal insufficiency in adults
Martin‐Grace, J., Tomkins, M., O’Reilly, M., & Sherlock, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00929-x · Cited by 40
Self-citationEndocrine aspects and sequel in patients with craniopharyngioma
Erfurth, E. M. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0419 · Cited by 40
Efficacy and complications of neurosurgical treatment of acromegaly
Krzentowska, A., Gołkowski, F., Bałdys‐Waligórska, A., & Hubalewska–Dydejczyk, A. (2010) · Pituitary · doi:10.1007/s11102-010-0273-0 · Cited by 42
Melmed, S. K., & Kleinberg, D. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00009-5 · Cited by 39
Melmed, S. K., & Kleinberg, D. L. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00009-2 · Cited by 38
Cardiovascular and Metabolic Impact of Glucocorticoid Replacement Therapy
Johannsson, G., & Ragnarsson, Ó. (2014) · Frontiers of hormone research · doi:10.1159/000360556 · Cited by 39
Ngaosuwan, K., Johnston, D. G., Godsland, I. F., Cox, J., Majeed, A., Quint, J. K., Oliver, N. S., & Robinson, S. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab063 · Cited by 35
Stewart, P. M., & Newell-Price, J. D. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00015-0 · Cited by 35
Self-citationGheorghiu, M. L., & Fleseriu, M. (2017) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2017.476 · Cited by 33
Hydrocortisone Dosing for Hypotension in Newborn Infants: Less Is More
Watterberg, K. L. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.04.005 · Cited by 33
Ragnarsson, O., Nyström, H. F., & Johannsson, G. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04174.x · Cited by 31
Factors impacting on the action of glucocorticoids in patients receiving glucocorticoid therapy
Dineen, R., Stewart, P. M., & Sherlock, M. (2019) · Clinical Endocrinology · doi:10.1111/cen.13837 · Cited by 30
Self-citationUpdate in Mortality in GH-Treated Patients
Erfurth, E. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2415 · Cited by 30
Yuan, X., Zhu, H., Pan, H., Chen, S., Liu, Z., Li, Y., Wang, L., Lü, L., Yang, H., & Gong, F. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i14.1741 · Cited by 29
Behan, L.-A., Carmody, D., Rogers, B., Hannon, M. J., Davenport, C., Tormey, W., Smith, D., Thompson, C. J., Stanton, A., & Agha, A. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1187 · Cited by 28
Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis
de Moura, C. R., Lopes, S. G. D. C., & Monteiro, A. M. (2022) · Pituitary · doi:10.1007/s11102-022-01256-6 · Cited by 28
The changing landscape of acromegaly – an epidemiological perspective
Rosendal, C., Arlien-Søborg, M. C., Nielsen, E. H., Andersen, M., Feltoft, C. L., Kistorp, C., Dekkers, O. M., Jørgensen, J. O. L., & Dal, J. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09875-z · Cited by 28
Yedinak, C., Hameed, N., Gassner, M., Brzana, J., McCartney, S., & Fleseriu, M. (2015) · Pituitary · doi:10.1007/s11102-015-0643-8 · Cited by 27
Behan, L., Rogers, B., Hannon, M. J., O’Kelly, P., Tormey, W., Smith, D., Thompson, C. J., & Agha, A. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04074.x · Cited by 27
Improving glucocorticoid replacement profiles in adrenal insufficiency
Choudhury, S., Lightman, S. L., & Meeran, K. M. (2019) · Clinical Endocrinology · doi:10.1111/cen.13999 · Cited by 26
Osorio, R. C., Oh, J. Y., Choudhary, N. R., Lad, M., Savastano, L. E., & Aghi, M. K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1064216 · Cited by 26
Ceccato, F., Torchio, M., Tizianel, I., Falb, M. P., Barbot, M., Sabbadin, C., Betterle, C., & Scaroni, C. M. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01889-1 · Cited by 25
Characterization of patients with adrenal insufficiency and frequent adrenal crises
Quinkler, M. O., Murray, R. D., Zhang, P., Marelli, C., Petermann, R., Isidori, A. M., Ekman, B., & _, _. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1324 · Cited by 26
Melmed, S. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00015-5 · Cited by 25
Role of pituitary dysfunction on cardiovascular risk in primary empty sella patients
Colao, A., Cotta, O. R., Ferone, D., Torre, M. L., Ferraù, F., Somma, C. D., Boschetti, M., Teti, C., Savanelli, M. C., Alibrandi, A., et al. (2013) · Clinical Endocrinology · doi:10.1111/cen.12122 · Cited by 24
Olsson, D. S., Bryngelsson, I., & Ragnarsson, Ó. (2016) · Pituitary · doi:10.1007/s11102-016-0764-8 · Cited by 24
Pituitary tumors and the risk of other malignancies: is the relationship coincidental or causal?
Pekić, S., Stojanović, M., & POPOVIC, V. M. (2021) · Endocrine Oncology · doi:10.1530/eo-21-0033 · Cited by 24
Approach to the Patient With Treatment-resistant Acromegaly
Coopmans, E. C., van der Lely, A. J., & Neggers, S. J. C. M. M. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac037 · Cited by 24
Behan, L.-A., Kelleher, G., Hannon, M. J., Brady, J. J., Rogers, B., Tormey, W., Smith, D., Thompson, C. J., McKenna, M. J., & Agha, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0596 · Cited by 23
Garrahy, A., & Agha, A. (2016) · BMC Endocrine Disorders · doi:10.1186/s12902-016-0117-7 · Cited by 23
Qiao, N., He, M., Shen, M., Zhang, Q., Zhang, Z., Shou, X., Wang, Y., Zhao, Y., & Tritos, N. A. (2020) · Endocrine Practice · doi:10.4158/ep-2019-0528 · Cited by 23
Secondary adrenal insufficiency: Where is it hidden and what does it look like?
Guaraldi, F., Karamouzis, I., Berardelli, R., D'Angelo, V., Rampino, A., Zichi, C., Ghigo, E., & Giordano, R. (2016) · Frontiers of hormone research · doi:10.1159/000443915 · Cited by 22
Saving lives of patients with adrenal insufficiency: a pan‐ European initiative?
Quinkler, M., Hahner, S., Johannsson, G., & Stewart, P. M. (2014) · Clinical Endocrinology · doi:10.1111/cen.12378 · Cited by 22
Self-citationAuer, M. K., Stalla, G. K., & Stieg, M. R. (2016) · Pituitary · doi:10.1007/s11102-016-0726-1 · Cited by 22
(2023) · Folia Endocrinologica Japonica · doi:10.1507/endocrine.99.s.july_1 · Cited by 22
Metadata
- Authors
- Sherlock, M., Reulen, R. C., Alonso, A. A., Ayuk, J., Clayton, R. N., Sheppard, M. C., Hawkins, M. M., Bates, A. S., & Stewart, P. M.
- Affiliations
- University of Birmingham (GB)
- Centre for Endocrinology, Diabetes and Metabolism (M.S., A.A.A., J.A., M.C.S., P.M.S.), School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TH, United Kingdom
- Keele University (GB)
- National Health Service (GB)
- Corresponding author
- Stewart, P. M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-11-01
- Volume
- 94
- Issue
- 11
- Pages
- 4216-4223
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2079605343
- Semantic Scholar
- 2edc859ca1b96cf7ca9a2a1af8b57d431f6d7a0e
- Cited by
- 185
- References
- 56
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 12 · 2023: 9 · 2022: 11 · 2021: 14 · 2020: 8 · 2019: 10 · 2018: 14 · 2017: 9 · 2016: 22 · 2015: 12 · 2014: 11 · 2013: 10 · 2012: 13
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion)
- Funders
- Cancer Research UK
- National Institute for Health and Care Research (NF-SI-0508-10356)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Clinical Neurology › Meningioma and schwannoma management
- Keywords
- acromegaly, ACTH deficiency, hydrocortisone replacement, hydrocortisone dose, pituitary radiotherapy, hypopituitarism, gonadotropin deficiency, all-cause mortality, standardized mortality ratio, pituitary adenoma, TSH deficiency, mortality risk factors, long-term follow-up
- MeSH terms
- Acromegaly, Adrenocorticotropic Hormone, Cardiovascular Diseases, Cause of Death, Female, Follow-Up Studies, Humans, Hydrocortisone, Male, Neoplasms, Predictive Value of Tests, Radiotherapy, Respiratory Tract Diseases, Time Factors, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.